Vimarsana
Biggest News Aggregation in the World

Page 8 - Breakthrough Device Designations News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Breakthrough Device Designations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Breakthrough Device Designations Today - Breaking & Trending Today

Anumana Receives U.S. FDA Breakthrough Device Designation for its Cardiac Amyloidosis Algorithm - Vimarsana News

Anumana Receives U.S. FDA Breakthrough Device Designation for its Cardiac Amyloidosis Algorithm

Developed in collaboration with Mayo Clinic, with support from Pfizer, this ECG-AI algorithm aims to aid physicians in earlier identification of cardiac amyloidosis

New Natera Data to be Presented at the 2023 ASCO Annual Meeting in 13 Studies Across Multiple Cancer Types - Vimarsana News

New Natera Data to be Presented at the 2023 ASCO Annual Meeting in 13 Studies Across Multiple Cancer Types

Highlights include oral presentations in Sarcoma and CRC; immunotherapy monitoring data from the Phase 3 EMPOWER-Lung 1 study; updates from the CIRCULATE-Japan study in CRC ... | May 30, 2023

Brain Computer Interface (BCI) Enables Thought-Controlled Walking after Spinal Cord Injury - Vimarsana News

Brain Computer Interface (BCI) Enables Thought-Controlled Walking after Spinal Cord Injury

Pioneering study in Nature demonstrates that adding a BCI to ONWARD® ARC Therapy™ can enable thought-controlled standing, walking, and stair climbingEINDHOVEN, the Netherlands, May 24, 2023... | June 11, 2023

ONWARD Medical: Brain Computer Interface (BCI) Enables Thought-Controlled Walking after Spinal Cord Injury - Vimarsana News

ONWARD Medical: Brain Computer Interface (BCI) Enables Thought-Controlled Walking after Spinal Cord Injury

Pioneering study in Nature demonstrates that adding a BCI to ONWARD® ARC Therapy can enable thought-controlled standing, walking, and stair climbingEINDHOVEN, the Netherlands, May 24, 2023showing that

ONWARD Reports Q1 Business Update and Year-To-Date Highlights - Vimarsana News

ONWARD Reports Q1 Business Update and Year-To-Date Highlights

First-in-Human Use of the ARC-IM™ LeadNew Breakthrough Device Designation Awarded by the U.S. FDA for ARC Therapy™, Bringing Total to 9 10 Additional Patents Issued, Bringing Total Pending... | May 16, 2023